Products

LungVision
Body Vision Medical
Oncology AI
BodyVision Medical's LungVision system is an AI-powered intraoperative imaging and navigation platform that transforms 2D C-arm X-rays into real-time 3D CT-like scans for precise lung cancer diagnosis and intervention.
Lung Vision
Body Vision Medical
Oncology AI
LungVision by Body Vision Medical is an AI-powered, intraoperative imaging system that converts 2D C-arm images into real-time 3D views for precise navigation and visual confirmation during lung biopsies, enhancing early lung cancer detection and treatment.
Lung Vision System
Body Vision Medical
Oncology AI
The LungVision® System is an AI-powered, intraoperative imaging and navigation system from Body Vision Medical that transforms 2D C-arm images into real-time 3D for precise peripheral lung biopsy and intervention. It offers augmented fluoroscopy with tool-in-lesion confirmation, improving diagnostic yield and reducing radiation exposure.

See all 3 products →

About Body Vision Medical

Body Vision Medical is a commercial-stage medical device company specializing in AI-driven, real-time intraoperative imaging for the diagnosis and treatment of lung cancer. The company’s core product, LungVision™, is an AI-powered intraoperative imaging system that transforms X-ray images from any conventional 2D C-arm into real-time 3D tomographic images. This technology, known as AI Tomo®, addresses a significant challenge in lung cancer diagnostics: CT-to-body divergence, which is the shift in a lesion’s position between a pre-operative CT scan and the actual bronchoscopy procedure. By correcting for this divergence, LungVision enables visual confirmation of tool-in-lesion during endobronchial biopsies, empowering bronchoscopists to biopsy from smaller, more difficult-to-access lung lesions and improving diagnostic accuracy and yield.

For physicians, LungVision offers enhanced accuracy and confidence during lung cancer diagnostic and therapeutic procedures. It provides real-time, high-precision navigation for biopsy of pulmonary lesions and the delivery of localized therapies. The system is designed to integrate seamlessly with existing bronchoscopy equipment, including robotic platforms, making it a cost-effective solution for hospitals and cancer centers. Body Vision Medical aims to improve patient outcomes by facilitating earlier lung cancer detection and more precise interventions, ultimately bridging the gap between early detection and improved patient survival rates.

Focus Areas

AI-powered imaging lung cancer diagnosis intraoperative imaging real-time 3D imaging navigation bronchoscopy medical devices oncology diagnostics

Business Intelligence

TechnologyAI-powered, intraoperative imaging system (LungVision®) that transforms 2D C-arm X-ray images into real-time 3D tomographic images (AI Tomo®). Cloud-based machine learning and multi-modality image registration.

What Physicians Need to Know

Specialization
Body Vision Medical specializes in AI-driven advanced imaging technology for real-time, high-precision navigation in lung cancer diagnostics and localized therapies. Their flagship product, LungVision®, focuses on improving the diagnostic yield of bronchoscopies for pulmonary lesions.
Key Differentiators
Body Vision Medical's key differentiators include their proprietary AI Tomo® technology, which transforms any 2D C-arm into an advanced 3D imaging system, correcting for CT-to-body divergence and enabling visual tool-in-lesion confirmation. This significantly increases diagnostic yields (approaching 95%) compared to traditional bronchoscopy (often below 70%). They offer a hardware-light, affordable, and mobile solution that provides superior image quality at a significantly reduced radiation dose (approximately 1/5th of a 3D C-arm).
Technology Stack
The core of their technology stack is the LungVision® system, which utilizes proprietary AI algorithms to fuse preoperative CT scans with intraoperative fluoroscopy. This AI-powered system generates real-time 3D imaging from conventional 2D C-arm X-ray images.
Physician Tip

For physicians, Body Vision Medical's LungVision system offers real-time, intraoperative 3D imaging and augmented fluoroscopy, allowing for accurate navigation and visual confirmation of biopsy tool placement within lung lesions, even small and peripheral ones. This can lead to diagnostic yields approaching 90% and beyond, reducing the need for repeat procedures and improving patient outcomes. The system integrates seamlessly with existing C-arms, bronchoscopes (including robotic), and biopsy tools, making it a flexible and cost-effective solution. It also significantly reduces radiation exposure for both patients and staff.

The LungVision system is designed for seamless integration with various existing equipment, including 2D and 3D C-arms, navigation platforms, bronchoscopes (both manual and robotic), and standard biopsy tools. It can function as a standalone platform or augment robotic bronchoscopy systems.

Products by Body Vision Medical

3 products in the directory

LungVision
Body Vision Medical
Oncology AI
BodyVision Medical's LungVision system is an AI-powered intraoperative imaging and navigation platform that transforms 2D C-arm X-rays into real-time 3D CT-like scans for precise lung cancer diagnosis and intervention.
Lung Vision
Body Vision Medical
Oncology AI
LungVision by Body Vision Medical is an AI-powered, intraoperative imaging system that converts 2D C-arm images into real-time 3D views for precise navigation and visual confirmation during lung biopsies, enhancing early lung cancer detection and treatment.
Lung Vision System
Body Vision Medical
Oncology AI
The LungVision® System is an AI-powered, intraoperative imaging and navigation system from Body Vision Medical that transforms 2D C-arm images into real-time 3D for precise peripheral lung biopsy and intervention. It offers augmented fluoroscopy with tool-in-lesion confirmation, improving diagnostic yield and reducing radiation exposure.

What the Web Says

Body Vision Medical, particularly with its LungVision product, generally receives positive feedback for its innovative AI-driven technology in lung cancer diagnosis, improving accuracy and early detection. Employer reviews, though limited, suggest a positive work environment with a focus on cutting-edge medical advancements.

Overall: Positive

Strengths

  • AI-driven technology enhances diagnostic accuracy for lung cancer.
  • Improves early detection of lung cancer, leading to better patient outcomes.
  • LungVision system is praised for its advanced imaging capabilities.
  • Positive impact on patient care and clinical workflow.
  • Company is seen as innovative and at the forefront of medical technology.
  • Regulatory approvals (e.g., in Australia) expand access to advanced diagnostics.

Limitations

  • Limited number of employer reviews available, making it hard to form a comprehensive view.
  • Specific product cons or user challenges are not widely detailed in public reviews.
  • Potential for high cost of advanced medical technology, though not explicitly stated as a con in reviews.
  • As with any new technology, there might be a learning curve for medical professionals.
  • No significant negative product or company reviews found on major platforms.
  • Information on specific customer support experiences is not readily available.

Based on reviews from: Paragon Care News (regulatory approval), Glassdoor (limited employer reviews), Reddit (limited mentions, generally positive about technology impact), Healthcare IT review sites (general industry sentiment on AI in diagnostics)

Last updated: 2026-10-17

Videos

News, demos, and interviews about Body Vision Medical.

Loading videos...

Videos load interactively. If none appear, search YouTube for Body Vision Medical →

View all on YouTube

Press & Coverage

PR Newswire
Body Vision Medical Receives Regulatory Approval for LungVision® in Australia, Expanding Access to AI-Powered Advanced Imaging for Lung Cancer Diagnosis
Body Vision Medical announced that its LungVision advanced imaging system received regulatory approval from the Therapeutic Goods Administration (TGA) in Australia, marking a significant milestone in expanding access to AI-driven advanced imaging for lung cancer diagnosis.
2025-03
Body Vision Medical Press Release
Body Vision Medical Announces Departure of David Webster as CEO and Appoints Matt Baker as Successor
Body Vision Medical announced that Matt Baker, previously COO, was appointed as the new CEO, succeeding David Webster.
2024-07
Body Vision Medical Press Release
LungVision® Named “Best New Technology Solution - Biopsy” in 2024 MedTech Breakthrough Awards Program
Body Vision Medical's LungVision® system was recognized as the "Best New Technology Solution - Biopsy" in the 2024 MedTech Breakthrough Awards Program.
2024-06
Body Vision Medical Press Release
Body Vision Medical Signs Exclusive Distribution Agreement with AMCO Incorporated
Body Vision Medical signed an exclusive distribution agreement with AMCO Incorporated, expanding its global reach.
2024-06
Body Vision Medical Press Release
Body Vision Medical Announces Successful Validation of LungVision™ System with Fujifilm's Range of Surgical C-arms
Body Vision Medical announced the successful validation of its LungVision™ System with Fujifilm's range of surgical C-arms, demonstrating compatibility and enhanced imaging capabilities.
2024-03
PR Newswire
Body Vision Medical Receives FDA Clearance for LungVision 2.0 System, a Part of LungVision Platform, Demonstrated at ATS 2019
Body Vision Medical received FDA clearance for its LungVision™ 2.0 System, which features artificial intelligence tomography, fused imaging, cloud-based machine learning, and multi-modality image registration.
2019-05
Imaging Technology News
Body Vision Medical Receives FDA Clearance for LungVision Tool
Body Vision Medical received FDA clearance for its LungVision Tool, an affordable lung navigation catheter designed for use with standard bronchoscopes and the LungVision System.
2018-05
Medical Design and Outsourcing
Body Vision Medical Receives FDA Clearance For The LungVision Navigation System
Body Vision Medical received FDA clearance to market LungVision, a novel imaging system enabling accurate real-time navigation and lesion localization during bronchoscopic procedures.
2017-05

Frequently Asked Questions

Body Vision Medical offers the LungVision® System, an AI-powered intraoperative imaging system. This system transforms images from any 2D C-arm into 3D images for navigation bronchoscopy procedures, enabling physicians to accurately locate and biopsy small lung lesions in real-time.
Body Vision Medical's LungVision® system has received regulatory approvals in various regions, including Pre-Market Approval from Singapore's Health Sciences Authority (HSA), approval from the Therapeutic Goods Administration (TGA) in Australia, and regulatory approval from the Central Drugs Standard Control Organization (CDSCO) in India.
The LungVision® system is designed to be an affordable, low-cost solution with a hardware-light design. Body Vision Medical also offers a subscription model, allowing hospitals to acquire the system without significant upfront capital expenditure.
Body Vision Medical provides clinical training and case support to every customer after initial purchase. Their clinical education team offers refresher training, education for new staff, and advanced training for experienced users.
Body Vision Medical has established partnerships to expand its reach, including a national accounts partnership with Healthcare Links to increase access for GPO and IDN customers. They also have distribution agreements in numerous countries, such as Taiwan, Singapore, Israel, Brazil, and South Korea.
Body Vision Medical is a privately held company that has recently closed a new funding round to accelerate its global expansion. Their long-term vision is to democratize innovative medical technology and redefine lung cancer diagnostics and therapies through AI-driven imaging, aiming to improve early and accurate lung cancer diagnosis worldwide.

Related Companies

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]

SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]

NTL Healthcare is a South Korean AI-powered women’s health company specializing in cervical cancer screening and diagnostics. The company has a history dating back to 1996 when it first introduced an analog cervical cancer reading system, Cervicography, to Korea. Since then, NTL Healthcare has evolved its technology, developing the world’s first remote uterine cervical cancer […]

Lumonus is a healthcare technology company that specializes in AI-powered solutions for cancer care, particularly in radiation oncology. The company’s core offering is the Lumonus AI platform, a digital oncology system with AI-native clinical infrastructure designed to automate and orchestrate critical oncology workflows. This platform aims to enhance the quality and speed of care delivery […]

Qure.ai is a leading healthcare AI company that leverages deep learning and artificial intelligence to revolutionize medical imaging diagnostics and make healthcare more accessible and affordable globally. The company develops AI-powered solutions for interpreting X-rays and CT scans, addressing critical health needs in areas such as lung, musculoskeletal, cardiovascular, and neurocritical health. Their technology assists […]

Deep Bio is a healthcare AI company that develops deep learning-based cancer diagnostic support software, aiming to advance patient outcomes by empowering clinicians with innovative technology. Their mission is to provide tools that enable medical professionals to make critical decisions, ultimately enhancing healthcare delivery and allowing clinicians to focus more on patient care. The company’s […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.